1. |
Wang TB, Deng MH, Qiu WS, et al. Association of serum vascular endothelial growth factorC and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer [J]. World J Gastroenterol, 2007; 13(12): 17941798.
|
2. |
Matsumura S, Oue N, Mitani Y, et al. DNA demethylation of vascular endothelial growth factorC is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer [J]. Int J Cancer, 2007; 120(8): 16891695.
|
3. |
Mkinen T, Norrmén C, Petrova TV. Molecular mechanisms of lymphatic vascular development [J]. Cell Mol Life Sci, 2007; 64(15): 19151929.
|
4. |
Albuquerque RJ, Hayashi T, Cho WG, et al. Alternatively spliced vascular endothelial growth factor receptor2 is an essential endogenous inhibitor of lymphatic vessel growth [J]. Nat Med, 2009; 15(9): 10231030.
|
5. |
Morita H, Ishikawa Y, AkishimaFukasawa Y, et al. Histopathological predictor for regional lymph node metastasis in gastric cancer [J]. Virchows Arch, 2009; 454(2): 143151.
|
6. |
Nishi M, Abe Y, Tomii Y, et al. Cell binding isoforms of vascular endothelial growth factorA (VEGF189) contribute to blood flowdistant metastasis of pulmonary adenocarcinoma [J]. Int J Oncol, 2005; 26(6): 15171524.
|
7. |
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors [J]. Nat Med, 2003; 9(6): 669676.
|
8. |
Siegfried G, Basak A, Cromlish JA, et al. The secretory proprotein convertases furin, PC5, and PC7 activate VEGFC to induce tumorigenesis [J]. J Clin Invest, 2003; 111(11): 17231732.
|
9. |
Saharinen P, Tammela T, Karkkainen MJ, et al. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation [J]. Trends Immunol, 2004; 25(7): 387395.
|
10. |
Favier B, Alam A, Barron P, et al. Neuropilin2 interacts with VEGFR2 and VEGFR3 and promotes human endothelial cell survival and migration [J]. Blood, 2006; 108(4): 12431250.
|
11. |
Kim WH, Lee SH, Jung MH, et al. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF [J]. Exp Cell Res, 2009; 315(13): 21542164.
|
12. |
Matsumoto T, ClaessonWelsh L. VEGF receptor signal transduction [J]. Sci STKE, 2001; 2001(112): re21.
|
13. |
Li J, Huang S, Armstrong EA, et al. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor2 (VEGFR2) blockade [J]. Int J Radiat Oncol Biol Phys, 2005; 62(5): 14771485.
|
14. |
Caunt M, Mak J, Liang WC, et al. Blocking neuropilin2 function inhibits tumor cell metastasis [J]. Cancer Cell, 2008; 13(4): 331342.
|
15. |
Yuan L, Moyon D, Pardanaud L, et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice [J]. Development, 2002; 129(20): 47974806.
|
16. |
Su JL, Yang PC, Shih JY, et al. The VEGFC/Flt4 axis promotes invasion and metastasis of cancer cells [J]. Cancer Cell, 2006; 9(3): 209223.
|
17. |
Kodama M, Kitadai Y, Tanaka M, et al. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms [J]. Clin Cancer Res, 2008; 14(22): 72057214.
|
18. |
Li Q, Dong X, Gu W, et al. Clinical significance of coexpression of VEGFC and VEGFR3 in nonsmall cell lung cancer [J]. Chin Med J (Engl), 2003; 116(5): 727730.
|
19. |
Witte D, Thomas A, Ali N, et al. Expression of the vascular endothelial growth factor receptor3 (VEGFR3) and its ligand VEGFC in human colorectal adenocarcinoma [J]. Anticancer Res, 2002; 22(3): 14631466.
|
20. |
Neuchrist C, Erovic BM, Handisurya A, et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck [J]. Head Neck, 2003; 25(6): 464474.
|
21. |
Kaushal V, Mukunyadzi P, Dennis RA, et al. Stagespecific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advancedstage disease [J]. Clin Cancer Res, 2005; 11(2 Pt 1): 584593.
|
22. |
Weninger W, Partanen TA, BreitenederGeleff S, et al. Expression of vascular endothelial growth factor receptor3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi’s sarcoma tumor cells [J]. Lab Invest, 1999; 79(2): 243251.
|
23. |
Vondenhoff MF, Greuter M, Goverse G, et al. LT R signaling induces cytokine expression and upregulates lymphangiogenic factors in lymph node anlagen [J]. J Immunol, 2009; 182(9): 54395445.
|
24. |
Anisimov A, Alitalo A, Korpisalo P, et al. Activated forms of VEGFC and VEGFD provide improved vascular function in skeletal muscle [J]. Circ Res, 2009; 104(11): 13021312.
|
25. |
Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease [J]. Cancer Cell, 2002; 1(3): 219227.
|
26. |
Su JL, Chen PS, Chien MH, et al. Further evidence for expression and function of the VEGFC/VEGFR3 axis in cancer cells [J]. Cancer Cell, 2008; 13(6): 557560.
|
27. |
吴立刚, 刘奇伦, 胡志强. MMP2和VEGFC在甲状腺乳头状癌中的表达及临床意义 [J]. 中国普外基础与临床杂志, 2009; 16(11): 906910.
|
28. |
黄桂林, 侯吉学, 吴毅平, 等. 乳腺癌患者血清VEGFC水平与癌组织CerbB2蛋白的表达及临床意义 [J]. 中国普外基础与临床杂志, 2009; 16(7): 514517.
|
29. |
Da MX, Wu XT, Wang J, et al. Expression of cyclooxygenase2 and vascular endothelial growth factorC correlates with lymphangiogenesis and lymphatic invasion in human gastric cancer [J]. Arch Med Res, 2008; 39(1): 9299.
|
30. |
Gao P, Zhou GY, Zhang QH, et al. Lymphangiogenesis in gastric carcinoma correlates with prognosis [J]. J Pathol, 2009; 218(2): 192200.
|
31. |
Gao Y, Zhong WX, Mu DB, et al. Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors [J]. Ann Surg Oncol, 2008; 15(4): 11171123.
|
32. |
Arigami T, Natsugoe S, Uenosono Y, et al. Vascular endothelial growth factorC and D expression correlates with lymph node micrometastasis in pN0 early gastric cancer [J]. J Surg Oncol, 2009; 99(3): 148153.
|
33. |
Kabashima A, Maehara Y, Kakeji Y, et al. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma [J]. Oncology, 2001; 60(2): 146150.
|
34. |
He XW, Liu T, Chen YX, et al. Calcium carbonate nanoparticle delivering vascular endothelial growth factorC siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo [J]. Cancer Gene Ther, 2008; 15(3): 193202.
|
35. |
Iwata C, Kano MR, Komuro A, et al. Inhibition of cyclooxygenase2 suppresses lymph node metastasis via reduction of lymphangiogenesis [J]. Cancer Res, 2007; 67(21): 1018110189.
|